Gyre Therapeutics, Inc. GYRE GNI — Other Receivables
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Gyre Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherReceivables.
The official record: Gyre Therapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Gyre Therapeutics, Inc.'s gni — other receivables.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Gyre Therapeutics, Inc.'s GNI — other receivables?
- Gyre Therapeutics, Inc. (GYRE) reported GNI — other receivables of $200K in Q1 2026.
- How has Gyre Therapeutics, Inc.'s GNI — other receivables changed year-over-year?
- Gyre Therapeutics, Inc.'s GNI — other receivables decreased by 0.0% year-over-year, from $200K to $200K.
- What does GNI — other receivables mean?
- Represents amounts owed to the GNI segment from third parties that are not classified as standard trade accounts receivable. This metric highlights potential future cash inflows arising from non-core business activities or contractual arrangements. It provides insight into the segment's liquidity and the effectiveness of its revenue collection processes outside of primary sales.